Manohar Katakam | Chief Executive Officer
SteroTherapeutics

Manohar Katakam, Chief Executive Officer, SteroTherapeutics

Experienced biotech/pharma entrepreneur with more than 25 years of experience in developing and marketing a diverse therapeutic area products.   Dr. Katakam founded three companies, raised equity and debt capital, and managed operations leading to successful high-valued corporate exit strategies.    Major pharmaceutical industry experience included successful tenures at Centocor, Aventis, Wyeth and Pfizer.  Dr Katakam co-founded NuTherapeutics to develop and commercialize thin-film dosage forms of prescription products which he guided to a successful exit.  He established the orphan disease product company, Makindus, and led product development to Phase 3 readiness in both the US and in EU. He obtained his bachelor degree in pharmacy from Kakatiya University, and his MS and Ph.D. in Pharmaceutical Sciences from Auburn University.

Appearances:



Day 1 - World Orphan Drug Congress USA 2024 @ 15:20

ST-002: A promising therapy for the metabolic effects of hypercortisolemia and Cushing syndrome

last published: 25/Apr/24 18:55 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Gina McHugh
gina.mchugh@terrapinn.com
t/ +1 646 619 1775

 

 

 

Marketing & Press Opportunities

 
 

Kaylie Brogan
kaylie.brogan@terrapinn.com